COO

The Cooper Companies, Inc.
CAPPED RATING

The Cooper Companies Inc is a medical device company operating through its subsidiaries. It manufactures products for contact lens wearers and supplies women\'s health clinicians with products and treatment options to improve the delivery of healthcare.

The Cooper Companies, Inc. (COO) is rated C (2.3/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Profitability (B); its weakest is Revisions (F). The rating has held at C for 5 weeks.

Quantitative Factor Evaluation • Updated

Overall Rating
2.3 / 5.0
C
Value
B-
Factor Score 3.0 / 5.0
Growth
C+
Factor Score 2.7 / 5.0
Profitability
B
Factor Score 3.5 / 5.0
Momentum
C
Factor Score 2.5 / 5.0
Revisions
F
Factor Score 0.0 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio 21.5
EV / EBITDA 15.6
Rev Growth YoY 0.6%
Gross Margin 65.9%
Price Return 3M -16.6%
Price Return 12M -13.6%
Catalyst Signal -0.09
Market Cap $11.9B
TTM Revenue $4.2B
Price / Sales 2.8
ROE 6.8%

Historical Factor Score Progression

Held C for 5 weeks
Date Value Growth Profitability Momentum Revisions Overall
2026-11-16 B- (3.0) C+ (2.7) B (3.5) C (2.5) F (0.0) C (2.3)
2026-11-09 B- (3.0) C+ (2.7) B (3.5) C (2.3) F (0.0) C (2.3)
2026-11-02 B- (3.0) C+ (2.7) B (3.5) C (2.3) F (0.0) C (2.3)
2026-10-30 B- (3.0) C+ (2.7) B (3.5) C- (2.1) F (0.0) C (2.3)
2026-10-29 B- (3.0) C+ (2.7) B (3.5) C- (2.1) F (0.1) C (2.3)
Page 1 of 10
…